Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brenda J Grossman

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Mayo Clinic Proceedings|December 5, 2021
Improving Transfusion Practices Through Patient Blood Management ProgramsBrenda J Grossman
Transfusion|September 2, 2020
Therapeutic plasma exchange for iatrogenic hypertrigylceridemiaNicholas Gau, Brenda J Grossman
Transfusion|January 12, 2013
Antibody of undetermined specificity: frequency, laboratory features, and natural historyChang Liu, Brenda J Grossman
Hematology. American Society of Hematology. Education Program|December 6, 2015
Red blood cell transfusion for hematologic disordersChang Liu, Brenda J Grossman
Clinical Chemistry|November 10, 2010
Red cell transfusion decreases hemoglobin A1c in patients with diabetesDavid H Spencer, Brenda J Grossman, Mitchell G Scott
International Journal of Hematology|July 26, 2018
Transfusion requirements and 30-day mortality predictors for adult hemophagocytic lymphohistiocytosisZaher K Otrock, Brenda J Grossman, Charles S Eby
Transfusion|August 18, 2009
Liver donor's age and recipient's serum creatinine predict blood component use during liver transplantationKian A Modanlou, Dana A Oliver, Brenda J Grossman
Transfusion|August 22, 2012
Platelet recovery rate during plasma exchange predicts early and late responses in patients with thrombotic thrombocytopenic purpuraChang Liu, Dorina Kallogjeri, Marian Dynis, et al.
American Journal of Hematology|February 24, 2006
RhD alloimmunization without apparent exposure to RhD antigenGanesh C Kudva, Kent D Branson, Brenda J Grossman
Transfusion|January 11, 2020
The CELLEX is comparable to the UVAR-XTS for the treatment of acute and chronic graft versus host disease (GVHD)Amber Afzal, Maryna Tarbunova, George Despotis, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Mayo Clinic Proceedings|December 5, 2021
Improving Transfusion Practices Through Patient Blood Management ProgramsBrenda J Grossman
Transfusion|September 2, 2020
Therapeutic plasma exchange for iatrogenic hypertrigylceridemiaNicholas Gau, Brenda J Grossman
Transfusion|January 12, 2013
Antibody of undetermined specificity: frequency, laboratory features, and natural historyChang Liu, Brenda J Grossman
Hematology. American Society of Hematology. Education Program|December 6, 2015
Red blood cell transfusion for hematologic disordersChang Liu, Brenda J Grossman
Clinical Chemistry|November 10, 2010
Red cell transfusion decreases hemoglobin A1c in patients with diabetesDavid H Spencer, Brenda J Grossman, Mitchell G Scott
International Journal of Hematology|July 26, 2018
Transfusion requirements and 30-day mortality predictors for adult hemophagocytic lymphohistiocytosisZaher K Otrock, Brenda J Grossman, Charles S Eby
Transfusion|August 18, 2009
Liver donor's age and recipient's serum creatinine predict blood component use during liver transplantationKian A Modanlou, Dana A Oliver, Brenda J Grossman
Transfusion|August 22, 2012
Platelet recovery rate during plasma exchange predicts early and late responses in patients with thrombotic thrombocytopenic purpuraChang Liu, Dorina Kallogjeri, Marian Dynis, et al.
American Journal of Hematology|February 24, 2006
RhD alloimmunization without apparent exposure to RhD antigenGanesh C Kudva, Kent D Branson, Brenda J Grossman
Transfusion|January 11, 2020
The CELLEX is comparable to the UVAR-XTS for the treatment of acute and chronic graft versus host disease (GVHD)Amber Afzal, Maryna Tarbunova, George Despotis, et al.
Pageof 5